Abstracts

BONE, RENAL, AND INFLAMMATION MARKERS IN THE DOLUTEGRAVIR MONOTHERAPY (DOMONO) STUDY

Tenofovir disoproxil fumarate (TDF) containing combination antiretroviral therapy (cART) can result in unfavorable metabolic changes. These may recover after TDF discontinuation. We measured renal, bone, lipid and inflammatory markers before and after a switch from TDF-containing cART to dolutegravir (DTG) monotherapy in the DOlutegravir maintenance MONOtherapy for HIV (DOMONO) study (NCT02401828). In DOMONO patients were…

OMEGA-3 FATTY ACID SUPPLEMENTATION IN HIV PATIENTS: A RANDOMIZED CLINICAL TRIAL

Osteopenia and osteoporosis are common comorbidities in HIV-infected patients and low level residual systemic inflammation is thought to be a contributor to these disorders. Omega-3 fatty acids (O3FAs) have beneficial effects on triglycerides and systemic inflammation. The anti-inflammatory effects of O3FAs are well-known and they are mediated through multiple mechanisms. We performed a randomized clinical…

HYPERKYPHOSIS AND AGING IN THE WOMEN’S INTERAGENCY HIV STUDY

HIV+ women have lower bone mineral density (BMD) and a higher rate of fracture than HIV- women, but the contribution of HIV infection to hyperkyphosis is not known. Hyperkyphosis is a geriatric syndrome of multifactorial etiology including decreased BMD, vertebral fracture, and muscle weakness, and is associated with decreased physical function and increased all-cause mortality.…